1-3 of 3
Monica Sanchez-Cardenas, MD
Close
Sort by
Journal Articles

Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

David Gomez-Almaguer, MD, Olga Cantu-Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, MD, Jose Carlos Jaime-Perez, MD PhD, Luz C. Tarin-Arzaga, MD, Monica Sanchez Cardenas, MD, Rosa Elena Lozano-Morales, MD, Guillermo Sotomayor Duque, MD, Daniela Cárdenas-Araujo, MD, Andres Gomez-de Leon, MD, Paola Santana-Hernandez, Perla Rocío Colunga-Pedraza, MD
Journal: Blood
Blood (2016) 128 (22): 1369.
https://doi.org/10.1182/blood.V128.22.1369.1369
Published: 2016
Journal Articles

Prevalence Of FLT3 Mutations In Acute Myeloid Leukemia: A Multicenter Latin America Study

Jorge Cuervo-Sierra, MD, David Gómez-Almaguer, MD, Jose Carlos Jaime-Pérez, MD, Ramón Alejandro Martínez-Hernández, MD, Ricardo David García Sepúlveda, MD, Mónica Sánchez-Cárdenas, MD, Rocio Ortiz-López, MD, Gregorio Ignacio-Ibarra, MD, Gabriel Muciño-Hernández, MD, Rosa Maria Arana-Trejo, MD, Guillermo J. Ruiz-Arguelles, MD, FRCP (Glasg), MACP, Guillermo J. Ruiz-Delgado, MD, Julia Lutz-Prestno, MD, Angélica Jiménez-Mejía, MD, Gonzalo Vásquez-Palacio, Biol. Esp. Msc., Mauricio Camargo-Guerrero, MD
Journal: Blood
Blood (2013) 122 (21): 4979.
https://doi.org/10.1182/blood.V122.21.4979.4979
Published: 2013
Journal Articles

Is There a Benefit of Adding Rituximab to CHOP in the Overall Survival of Patients with B-Cell Non-Hodgkin′s Lymphoma in a Developing Country ?

Guillermo J. Ruiz-Delgado, MD, David Gomez Almaguer, MD, Luz C. Tarin-Arzaga, MD, Olga Cantú-Rodríguez, MD, Carlos Alarcon-Urdaneta, MD, Uxmal Rodriguez-Morales, MD, Jackeline Calderon-García, MD, Omar Fernandez-Vargas, MD, Maryel Montes-Montiel, MD, Monica Sanchez-Cardenas, MD, Guillermo J. Ruiz-Arguelles, MD, FACP, FRCP (Glasg)
Journal: Blood
Blood (2012) 120 (21): 4892.
https://doi.org/10.1182/blood.V120.21.4892.4892
Published: 2012